The DNA Gyrase B ATP binding domain of Escherichia coli in complex with a small molecule inhibitor.
Daniel C. Bensen(State Street (United States)), L.W. Tari(Arcturus Therapeutics (United States)), Thanh Lam(Arcturus Therapeutics (United States)), S. Akers-Rodriguez(Arcturus Therapeutics (United States))
Cited by 1
Related Papers
Comparative Genomic Analysis of Archaeal Genotypic Variants in a Single Population and in Two Different Oceanic Provinces
|Applied and Environmental Microbiology|2002|171
Pyrrolopyrimidine inhibitors of DNA gyrase B (GyrB) and topoisomerase IV (ParE). Part I: Structure guided discovery and optimization of dual targeting agents with potent, broad-spectrum enzymatic activity
|Bioorganic & Medicinal Chemistry Letters|2012|118
Tricyclic GyrB/ParE (TriBE) Inhibitors: A New Class of Broad-Spectrum Dual-Targeting Antibacterial Agents
|PLoS ONE|2013|104
Pyrrolopyrimidine inhibitors of DNA gyrase B (GyrB) and topoisomerase IV (ParE), Part II: Development of inhibitors with broad spectrum, Gram-negative antibacterial activity
|Bioorganic & Medicinal Chemistry Letters|2012|81